Preview

Научно-практическая ревматология

Расширенный поиск

Показатели эффективности препаратов для лечения остеопороза: снижение относительного и абсолютного риска

https://doi.org/10.14412/1995-4484-2011-869

Полный текст:

Список литературы

1. <div><p>Black D.M., Cummings S.R., Karpf D.B. et al. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996; 348: 1535-41.</p><p>Black D.M., Delmas P.D., Eastell R. et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007; 356(18): 1809-22.</p><p>Rossouw J.E., Anderson G.L., Prentice R.L. et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288(3): 321-33.</p><p>Reginster J.Y., Seeman E., De Vernejoul M.C. et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis treatment of peripheral osteoporosis (TROPOS) study. J Clin Endocr 2005; 90: 2816-22.</p><p>Власов В.В. Эпидемиология: Учеб. пособие для вузов. М.: ГЭОТАР-Мед, 2004; 464 с.</p><p>Остеопороз. Под ред. О.М. Лесняк, Л.И. Беневоленской. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2009; 272 с.</p><p>Chapuy М.С., Arlot М.Е., Delmas P.D., Meunier P.J. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. Brit Med J 1994; 308(6936): 1081-2.</p><p>Jackson R.D., LaCroix A.Z., Gass M. et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354(7): 669-83.</p><p>Meunier P.J., Roux C., Seeman E. et al. The effects of Strontium Ranelate on the risk of vertebral fracture in women with post- menopausal osteoporosis. N Engl J Med 2004; 350: 459-68.</p><p>Chesnut C.H. III, Skag A., Christiansen C. et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 2004; 19(8): 1241-9.</p><p>Chesnut C.H. III, Silverman S., Andriano K. et al. A randomized trial of nasal spray salmon calcitonin in post- menopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 2000; 109: 267-76.</p><p>Roux C., Reginster J.Y., Fechtenbaum J. Vertebral fracture risk reduction with strontium ranelate in women with post- menopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res 2006; 21(4): 536-42.</p><p>Duehmke R.M., Hollingshead J., Cornblath D.R. Tramadol for neuropathic pain. Cochrane Database of Systematic Reviews 2006; Issue 3; Art. No.: CD003726. DOI:</p></div><br />


Для цитирования:


Evstigneeva L.P., Лесняк О.М., Evstigneyeva L.P., Лесняк О.М. Показатели эффективности препаратов для лечения остеопороза: снижение относительного и абсолютного риска. Научно-практическая ревматология. 2011;49(1):62-65. https://doi.org/10.14412/1995-4484-2011-869

For citation:


Evstigneeva L.P., Lesnyak O.M., Evstigneyeva L.P., Lesnyak O.M. The efficacy of drugs for the treatment of osteoporosis: reducing the relative and absolute risks. Rheumatology Science and Practice. 2011;49(1):62-65. (In Russ.) https://doi.org/10.14412/1995-4484-2011-869

Просмотров: 560


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)